Samrat Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the un-audited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem Limited has informed BSE that a meeting of the Board of Directors will be held on Friday, February 13, 2026 at 2:00 PM at the company's corporate office in Andheri West, Mumbai. The board will, among other items, consider and approve the unaudited financial results of the company under Ind-AS for the quarter ended December 31, 2025 (Q3 FY26). The results will be intimated to the exchanges after the meeting and also published on the company's website (www.samratpharmachem.com). The filing is a standard regulatory disclosure under SEBI LODR Regulation 29(2) and contains no actual financial figures.
This is a routine procedural announcement with no immediate impact on shareholders. Investors should watch for the actual Q3 results on or after February 13, 2026 to gauge the company's quarterly performance and any forward-looking commentary.